The Adult Cancer Immunotherapy Fellowship Program at Memorial Sloan Kettering Cancer Center is an independent, one-year program designed to prepare physicians for academic careers in Cancer Immunotherapy, including experience with clinical and/or laboratory research.
This fellowship is offered jointly by the MSK Adult Bone Marrow Transplantation Service, Cellular Therapeutics Center (CTC) and the Parker Institute for Cancer Immunotherapy (PICI) at MSK, and is supported by the PICI at MSK. MSK has been at the forefront of the developments of novel approaches to stem cell transplantation and cell therapy, including CAR T cells, cytotoxic T lymphocytes, NK cells, as well as a pioneer in the field of immunotherapy with cancer vaccines, checkpoint inhibitors, and additional immunotherapies.
The Fellowship provides training in inpatient and outpatient settings, with a specific focus on the different subspecialties within Hematopoietic Stem Cell Transplantation, Cellular Therapy, including gene engineering, and the use of immunotherapy approaches to cancer including cancer vaccines and checkpoint inhibitors.
Fellows will also have opportunities to participate in ongoing research projects or initiate an independent project. This process will be helped by the assigning of a mentor throughout the fellowship, who will ensure that the objectives of the fellow are met for the training year.
The program includes a wide variety of conferences that complement the clinical aspects. These are based on a disease management concept and will group physicians from different specialties who treat the disease in question. In addition to these patient-based conferences, weekly research meetings are held.
Deadline
March 1st of the preceding year.
Length of Program
1 year
Eligibility
Board-eligible or board-certified graduates of an accredited US Hematology/Oncology fellowship program or equivalent.
Number of Positions
1
How to Apply
Please send an updated CV and personal statement to Brian Shaffer, MD at the address below. Three letters of recommendation should also be sent directly to Dr. Shaffer.
Additional Information
Learn more about our Blood and Marrow Stem Cell Transplantation Program.